Longevity PapersAbout
← All papers
RESEARCH PAPER / 2025-10-10

Multi-omics Mendelian Randomization and Single-Cell Analysis Identify Novel Therapeutic Targets for Osteosarcopenia.

Jiyong Yang, Miaoling Gong, Yi Zhou, Jifeng Zhao, Weijian Chen, Wengang Liu

The Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510095, Guangdong, China. · pubmed

Abstract

Osteosarcopenia, defined by the coexistence of osteoporosis and sarcopenia, presents a significant health challenge for aging populations. The purpose of current study was to identify potential therapeutic targets for osteosarcopenia using integrative analysis methods, including multi-omics Mendelian Randomization (MR) and single-cell RNA sequencing (scRNA-seq).

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The study identifies potential therapeutic targets for osteosarcopenia through multi-omics Mendelian Randomization and single-cell analysis. Osteosarcopenia is a condition that affects aging populations, and targeting its underlying mechanisms could contribute to addressing age-related health challenges.

Author of this paper? Send a correction.